Literature DB >> 11704865

BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.

L Banerji1, J Glassford, N C Lea, N S Thomas, G G Klaus, E W Lam.   

Abstract

Cross-linking of the B cell antigen receptor (BCR) on immature WEHI 231 B cells results in G1 cell cycle arrest and apoptosis. Here we investigated the molecular mechanisms that are necessary and sufficient for these changes to occur. We show that BCR stimulation of WEHI 231 cells results in down-regulation of cyclin D2 and up-regulation of p27(Kip1), which are associated with pocket protein hypophosphorylation and E2F inactivation. Ectopic expression of p27(Kip1) by TAT-fusion protein or retroviral transduction is sufficient to cause G1 cell cycle arrest, followed by apoptosis. In contrast, over-expression of cyclin D2 overcomes the cell cycle arrest and apoptosis induced by anti-IgM, indicating that down-regulation of cyclin D2 is necessary for the cell cycle arrest and apoptosis activated by BCR stimulation. Thus, cyclin D2 and p27(Kip1) have opposing roles in these pathways and our data also suggest that cyclin D2 functions upstream of p27(Kip1) and the pRB pathway and therefore plays an essential part in integrating the signals from BCR with the cell cycle machinery. We next investigated which signal transduction pathways triggered by the BCR regulate cell proliferation and apoptosis via cyclin D2 and p27(Kip1). Inhibition of PI3-K signalling by LY294002 down-regulated cyclin D2 and up-regulated p27(Kip1) expression at both protein and RNA levels, mimicking the effects of BCR-stimulation. Furthermore, ectopic expression of a constitutively active form of AKT blocked the cell cycle arrest and apoptosis triggered by anti-IgM and also abrogated down-regulation of cyclin D2 and up-regulation of p27(Kip1) expression induced by BCR-engagement. These results indicate that BCR activation targets p27(Kip1) and cyclin D2 to mediate cell cycle arrest and apoptosis and that down-regulation of PI3-K/AKT activity post BCR stimulation is necessary for these to occur.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704865     DOI: 10.1038/sj.onc.1204951

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.

Authors:  Caroline Bouchard; Judith Marquardt; Alexandra Brás; René H Medema; Martin Eilers
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

2.  Bcl-2 is a negative regulator of interleukin-1beta secretion in murine macrophages in pharmacological-induced apoptosis.

Authors:  J M Escandell; M C Recio; R M Giner; S Máñez; J L Ríos
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.

Authors:  Silvia Fernández de Mattos; Abdelkader Essafi; Inês Soeiro; Alexandra M Pietersen; Kim U Birkenkamp; Corinne S Edwards; Anthony Martino; Brad H Nelson; Julia M Francis; Marius C Jones; Jan J Brosens; Paul J Coffer; Eric W-F Lam
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

4.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing.

Authors:  Kristina Ottens; Rochelle M Hinman; Evan Barrios; Brian Skaug; Laurie S Davis; Quan-Zhen Li; Diego H Castrillon; Anne B Satterthwaite
Journal:  J Immunol       Date:  2018-06-27       Impact factor: 5.422

6.  Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.

Authors:  Mark A Watson; David H Gutmann; Kelly Peterson; Michael R Chicoine; Bette K Kleinschmidt-DeMasters; Henry G Brown; Arie Perry
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Commitment point during G0-->G1 that controls entry into the cell cycle.

Authors:  Nicholas C Lea; Stephen J Orr; Kai Stoeber; Gareth H Williams; Eric W-F Lam; Mohammad A A Ibrahim; Ghulam J Mufti; N Shaun B Thomas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway.

Authors:  Dairmuid M Moran; M Adrian Mattocks; Paul A Cahill; Leonidas G Koniaris; Iain H McKillop
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

9.  Cyclin D2 protein stability is regulated in pancreatic beta-cells.

Authors:  Lu Mei He; Daniel J Sartori; Monica Teta; Lynn M Opare-Addo; Matthew M Rankin; Simon Y Long; J Alan Diehl; Jake A Kushner
Journal:  Mol Endocrinol       Date:  2009-07-23

10.  Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.

Authors:  Etsuo Susaki; Keiko Nakayama; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.